INO vs VZ · $88.0M cap vs P/E 11, rev $34.25B
Inovio Pharmaceuticals Inc (INO) versus Verizon Communications Inc (VZ) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Verizon Communications Inc (VZ) is a telecom services company listed on NYSE. It is led by Hans Vestberg.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported VZ revenue for 2026-06-30 was $34.25B. Net income was $3.83B. Revenue was down 0.5% from 2026-03-31 to 2026-06-30. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
INO currently screens at market cap $88.0M. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
Not investment advice. Open the INO and VZ stock pages for the full models.
Not investment advice.